The research, conducted at Lakshmi Vaidyasala in Kakinada, evaluated a treatment approach targeting three key Covid-19-related complications: excessive inflammation, hypercoagulability and secondary bacterial infection. The regimen combined Aspirin, Prednisolone and Azithromycin.